LONDON, March 17, 2010 /PRNewswire-FirstCall/ -- Hikma Pharmaceuticals
today announced 2009 preliminary results with operating profits up 36% on the
back of a strong performance from its Middle East markets.
In a video interview on financial broadcaster http://www.cantos.com,
Group CEO Said